Takeda takeover

Quote






Right now I am sitting in my office, having voluntarily left Shire over one year ago. Hope that someone with sense comes in and cleans up the mess of Shire. They have no idea what they are in for in terms of culture. That place was hands down the worst place I ever worked filled with people who had no experience to head the departments they headed. Cronies, you are all screwed. I laugh as I sit in my warm, large cushy office.
 
























It will be a blood bath for the Shire sales force, RBD’s and ZD’s

Flemming is all about taking care of #1 (himself) Rewind to Abbvie.

The writing is on the wall, Shire is “for sale” to the highest bidder. The sales force will be GONE with the exception of a few.

Good Luck all!
 






anonymous said:
It will be a blood bath for the Shire sales force, RBD’s and ZD’s

Flemming is all about taking care of #1 (himself) Rewind to Abbvie.

The writing is on the wall, Shire is “for sale” to the highest bidder. The sales force will be GONE with the exception of a few.

Good Luck all!
Click to expand...

There will be layoffs on both sides trust me.
 












anonymous said:
Worst sales force in the industry? That makes sense. Vyvanse is only the 3rd most prescribed branded medication... amazing that the worst sales force was able to accomplish that.
Click to expand...
Look at the industry metric audits and Shire NBU is ranked in the lower tier for new Rx growth per rep. Takeda will cut all Shire reps!! Good riddance yall are donkey butts!
 


















Takeda said Wednesday it is weighing a bid for London-listed Shire, whose drugs include Adderall, for attention deficit hyperactivity disorder. The potential deal would create a global drug giant worth nearly $90 billion and add to a torrid run for mergers and acquisitions so far this year—much of it in health care as companies in the industry respond to a rapidly changing landscape.

A bid would represent Takeda’s biggest-ever deal, capping a string of smaller acquisitions in recent years aimed at broadening its international footprint. Takeda, founded in 1781 and Japan’s largest drugmaker by revenue and market capitalization, needs to keep expanding overseas to make up for a slowing market at home, analysts said.

If Takeda did nothing, “they’d only be waiting to die,” said Masayuki Kubota, chief strategist Rakuten Securities in Tokyo

When WSJ runs a story you know it has legs
 






In a statement Shire said it had noted Takeda’s disclosure but confirmed no approach had been made, adding there was no certainty an offer would ensue. Takeda said that under U.K. takeover rules, it must announce by April 25 whether it intends to make an offer for Shire.
 






Dear Takeda - Please buy Shire and help fix the place.

Dear Flemming - Note that the best thing to happen to our stock in the past year has been a takeover overture. Please self reflect on what this means.
 












anonymous said:
Don't forget Flem selling everyone's asses by negotiating away the severance package with AbbVie. He took care of his Dirty 30 with enhanced retention bonuses.
Click to expand...

This is very accurate. No wonder why the entire company sees this SOB as a snake and not to be trusted. 98% of Shire would benefit with phlegm gone. The 2% will do everything in their power to keep him, including fing the employees and doing things detrimental to business.

This guy is the definition of a self serving POS
 
























anonymous said:
They Have New HQ opening in July 2018 In Japan
Click to expand...

Takeda will evaluate consolidating Shire's operations into its own in the Boston area, Switzerland and Singapore, with the combined company's workforce of around 52 000 employees likely to be cut by between 6 percent and 7 percent. Deal closes first half of 2019.
 






Top Bottom
Back
Quote